BOSTON SCIENTIFIC CORP 8-K

What Happened
On February 4, 2026, Boston Scientific Corporation (BSX) issued and furnished a press release announcing its financial results for the fourth quarter and full year ended December 31, 2025. The company filed this information on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition); the press release is included as Exhibit 99.1.

Key Details

• Filing date: February 4, 2026 (Form 8‑K, Accession No. 0000885725-26-000006).
• Period reported: fourth quarter and full year ended December 31, 2025.
• Exhibit furnished: 99.1 (press release); Exhibit 104 is the cover page Interactive Data File (Inline XBRL).
• Form 8‑K signed by Susan Thompson, Vice President, Chief Corporate Counsel and Assistant Secretary.

Why It Matters
This 8‑K notifies investors that Boston Scientific has released its latest quarterly and annual operating results; those figures (revenue, earnings, cash flow, and any management commentary or guidance) will appear in the attached press release (Exhibit 99.1). Retail investors should review the press release and the company’s subsequent SEC filings (quarterly/annual reports and any accompanying presentations) to see the specific revenue and earnings figures and assess any impact on valuation or near‑term outlook.